background image

Paid Clinical Trials Ohio

Discover 3,036 paid clinical trials in Ohio. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Willoughby Hills, Willoughby, Mentor, Boardmanshow 93 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting
PHASE2
PHASE3

Sponsor:

Emory University

Location:

Columbus, Cleveland, Cincinnati, Detroitshow 32 more

Code:

NCT04167527

Conditions

Cerebral Ischemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device

Initial medical management (iMM)

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Recruiting
PHASE2

Sponsor:

New York Medical College

Location:

Columbus, Indianapolis, Milwaukee, Baltimoreshow 5 more

Code:

NCT03266627

Conditions

Adenovirus

Primary Immune Deficiency Disorder

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

cytotoxic t-lymphocytes

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Recruiting
PHASE1
PHASE2

Sponsor:

Neuracle Genetics, Inc

Location:

Cincinnati, Toronto, Vancouver

Code:

NCT05984927

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

NG101 AAV gene therapy

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Middleburg Heights, Grand Blanc, Okemos, Lexingtonshow 74 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

Recruiting
PHASE1
PHASE2

Sponsor:

Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Location:

Cleveland, Detroit, Buffalo, Milwaukeeshow 7 more

Code:

NCT04471727

Conditions

Small-Cell Lung Cancer

Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MK-6070

Atezolizumab

Ifinatamab Deruxtecan (I-DXd)

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Recruiting
PHASE2
PHASE3

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Location:

North Canton, Chicago, Allentown, Cherry Hillshow 12 more

Code:

NCT05729373

Conditions

Generalized Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

SEP-363856

Placebo

Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

Recruiting
PHASE3

Sponsor:

Intercytex

Location:

Columbus, Ann Arbor, Kittanning, Erieshow 34 more

Code:

NCT00232973

Conditions

Leg Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICXP007

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting
PHASE2
PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Columbus, Mentor, Cincinnati, Ann Arborshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)

Recruiting

Sponsor:

The Cleveland Clinic

Location:

Cleveland

Code:

NCT05757076

Conditions

Primary Aldosteronism

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Blood test for ARR

Popular cities in Ohio

With a robust healthcare network, renowned medical research centers, and innovative treatments, Ohio is a leading destination for a wide range of clinical trials. Institutions such as the Cleveland Clinic, Ohio State University Wexner Medical Center, University Hospitals Cleveland Medical Center, and Nationwide Children’s Hospital are at the forefront of these studies.

Why choose Ohio for clinical trials?

Common conditions studied in Ohio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Ohio